Vaccination strategies in patients with IBD

Abstract

Patients with IBD are at increased risk of infection, in part owing to the disease itself, but mostly because of treatment with immunosuppressive drugs. Although many of these infections are vaccine-preventable, vaccination coverage in patients with IBD is extremely low. The vaccine strategies examined in this Review are based on data that enable us to provide practical advice for clinicians. Clinical evidence indicates that vaccines do not increase the risk of relapse in patients with IBD. Live vaccines are contraindicated in immunocompromised individuals, but inactivated vaccines can be safely administered. Most patients receiving immunosuppressive therapy develop an immune response after vaccination, but response rates might differ from those of nonimmunosuppressed individuals. Therefore, vaccination status should be checked and updated upon diagnosis of IBD.

DOI: 10.1038/nrgastro.2013.28

Cite this paper

@article{Gisbert2013VaccinationSI, title={Vaccination strategies in patients with IBD}, author={Javier P Gisbert and Mar{\'i}a Chaparro}, journal={Nature Reviews Gastroenterology &Hepatology}, year={2013}, volume={10}, pages={277-285} }